Legal & General Group PLC Dexcom Inc Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Dexcom Inc stock. As of the latest transaction made, Legal & General Group PLC holds 3,011,353 shares of DXCM stock, worth $228 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,011,353
Previous 3,011,353 -0.0%
Holding current value
$228 Million
Previous $202 Million -0.0%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$64.0 - $116.06 $1.17 Million - $2.12 Million
18,304 Added 0.61%
3,011,353 $202 Million
Q2 2024

Aug 14, 2024
BUY
$110.31 - $140.45 $5.41 Million - $6.89 Million
49,076 Added 1.67%
2,993,049 $339 Million
Q1 2024

Jul 01, 2024
BUY
$114.22 - $140.1 $3.97 Million - $4.87 Million
34,743 Added 1.19%
2,943,973 $408 Million
Q1 2024

May 14, 2024
SELL
$114.22 - $140.1 $8.18 Million - $10 Million
-71,595 Reduced 2.4%
2,909,230 $404 Million
Q4 2023

Feb 15, 2024
BUY
$75.49 - $124.16 $36.4 Million - $59.9 Million
482,735 Added 19.32%
2,980,825 $370 Million
Q3 2023

Nov 14, 2023
SELL
$86.06 - $137.93 $9.05 Million - $14.5 Million
-105,186 Reduced 4.04%
2,498,090 $233 Million
Q2 2023

Aug 14, 2023
BUY
$112.47 - $130.98 $10.1 Million - $11.7 Million
89,358 Added 3.55%
2,603,276 $335 Million
Q1 2023

May 15, 2023
BUY
$104.0 - $122.92 $6.11 Million - $7.22 Million
58,752 Added 2.39%
2,513,918 $292 Million
Q4 2022

Feb 14, 2023
SELL
$84.98 - $122.67 $10.9 Million - $15.8 Million
-128,671 Reduced 4.98%
2,455,166 $278 Million
Q3 2022

Nov 14, 2022
SELL
$76.35 - $94.18 $6.19 Million - $7.63 Million
-81,043 Reduced 3.04%
2,583,837 $208 Million
Q2 2022

Aug 22, 2022
BUY
$67.99 - $132.89 $138 Million - $269 Million
2,027,129 Added 317.86%
2,664,880 $199 Million
Q1 2022

May 16, 2022
BUY
$94.08 - $130.2 $4.72 Million - $6.53 Million
50,151 Added 8.53%
637,751 $326 Million
Q4 2021

Feb 14, 2022
SELL
$129.87 - $162.82 $5.16 Million - $6.47 Million
-39,711 Reduced 6.33%
587,600 $316 Million
Q3 2021

Nov 15, 2021
BUY
$106.71 - $143.18 $1.98 Million - $2.65 Million
18,541 Added 3.05%
627,311 $343 Million
Q2 2021

Aug 12, 2021
BUY
$80.99 - $107.93 $4.08 Million - $5.43 Million
50,331 Added 9.01%
608,770 $260 Million
Q1 2021

May 17, 2021
BUY
$84.79 - $104.74 $116,247 - $143,598
1,371 Added 0.25%
558,439 $201 Million
Q4 2020

Feb 12, 2021
SELL
$78.0 - $104.5 $916,734 - $1.23 Million
-11,753 Reduced 2.07%
557,068 $206 Million
Q3 2020

Nov 13, 2020
BUY
$95.51 - $112.95 $2.02 Million - $2.39 Million
21,134 Added 3.86%
568,821 $234 Million
Q2 2020

Aug 14, 2020
BUY
$62.68 - $105.34 $2.21 Million - $3.72 Million
35,295 Added 6.89%
547,687 $222 Million
Q1 2020

May 14, 2020
BUY
$47.79 - $75.63 $722,871 - $1.14 Million
15,126 Added 3.04%
512,392 $138 Million
Q4 2019

Feb 13, 2020
BUY
$36.62 - $57.29 $614,556 - $961,440
16,782 Added 3.49%
497,266 $109 Million
Q3 2019

Nov 13, 2019
BUY
$35.53 - $43.8 $51,092 - $62,984
1,438 Added 0.3%
480,484 $71.7 Million
Q2 2019

Aug 14, 2019
SELL
$27.84 - $38.92 $174,027 - $243,288
-6,251 Reduced 1.29%
479,046 $71.8 Million
Q1 2019

May 15, 2019
BUY
$28.07 - $38.18 $9.24 Million - $12.6 Million
329,168 Added 210.83%
485,297 $57.8 Million
Q4 2018

Feb 15, 2019
BUY
$26.99 - $37.37 $2.58 Million - $3.57 Million
95,637 Added 158.1%
156,129 $18.7 Million
Q3 2018

Nov 20, 2018
BUY
$23.35 - $36.72 $422,051 - $663,714
18,075 Added 42.61%
60,492 $8.65 Million
Q2 2018

Aug 10, 2018
SELL
$17.54 - $25.22 $44,990 - $64,689
-2,565 Reduced 5.7%
42,417 $4.03 Million
Q1 2018

May 17, 2018
SELL
$13.06 - $18.54 $8,580 - $12,180
-657 Reduced 1.44%
44,982 $3.34 Million
Q4 2017

Feb 13, 2018
BUY
$11.12 - $15.38 $507,505 - $701,927
45,639
45,639 $2.62 Million

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email